Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
French Guiana | 48 | 2024 | 51 | 4.610 |
Why?
|
Gold | 15 | 2024 | 488 | 3.720 |
Why?
|
Malaria | 15 | 2024 | 1249 | 3.400 |
Why?
|
Malaria, Vivax | 7 | 2024 | 168 | 2.000 |
Why?
|
Malaria, Falciparum | 7 | 2023 | 1077 | 1.780 |
Why?
|
Mining | 7 | 2024 | 93 | 1.480 |
Why?
|
Syphilis | 3 | 2022 | 243 | 1.370 |
Why?
|
Brazil | 14 | 2024 | 1250 | 1.060 |
Why?
|
Q Fever | 2 | 2023 | 38 | 0.990 |
Why?
|
Suriname | 5 | 2024 | 28 | 0.950 |
Why?
|
Leishmaniasis | 2 | 2022 | 67 | 0.940 |
Why?
|
Anaplasmosis | 2 | 2024 | 37 | 0.850 |
Why?
|
Antimalarials | 6 | 2024 | 909 | 0.830 |
Why?
|
Rickettsia Infections | 1 | 2022 | 8 | 0.830 |
Why?
|
Leptospirosis | 1 | 2022 | 45 | 0.790 |
Why?
|
Yellow Fever | 1 | 2022 | 54 | 0.780 |
Why?
|
Epidemics | 3 | 2022 | 517 | 0.680 |
Why?
|
Communicable Diseases | 2 | 2023 | 873 | 0.610 |
Why?
|
Tropical Medicine | 1 | 2018 | 52 | 0.570 |
Why?
|
Hepatitis B | 2 | 2022 | 711 | 0.570 |
Why?
|
Buruli Ulcer | 1 | 2017 | 11 | 0.570 |
Why?
|
Cocaine | 1 | 2022 | 947 | 0.570 |
Why?
|
Self Medication | 1 | 2018 | 115 | 0.570 |
Why?
|
Artemisinins | 2 | 2024 | 217 | 0.560 |
Why?
|
Communicable Disease Control | 2 | 2021 | 857 | 0.550 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 668 | 0.530 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2018 | 2043 | 0.520 |
Why?
|
Digestive System Diseases | 1 | 2017 | 152 | 0.510 |
Why?
|
Plasmodium falciparum | 4 | 2021 | 1741 | 0.490 |
Why?
|
Diagnostic Tests, Routine | 2 | 2018 | 789 | 0.490 |
Why?
|
Plasmodium vivax | 5 | 2024 | 203 | 0.470 |
Why?
|
Indians, North American | 1 | 2018 | 354 | 0.450 |
Why?
|
Anaplasma | 2 | 2024 | 5 | 0.440 |
Why?
|
Plasmodium | 1 | 2016 | 248 | 0.430 |
Why?
|
Animals, Wild | 2 | 2024 | 78 | 0.410 |
Why?
|
Congresses as Topic | 1 | 2018 | 812 | 0.410 |
Why?
|
Zoonoses | 3 | 2023 | 180 | 0.410 |
Why?
|
Morbidity | 1 | 2018 | 1755 | 0.400 |
Why?
|
Illness Behavior | 1 | 2011 | 23 | 0.390 |
Why?
|
HIV Infections | 6 | 2023 | 17569 | 0.390 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26379 | 0.320 |
Why?
|
Communicable Diseases, Emerging | 2 | 2023 | 148 | 0.320 |
Why?
|
Population Surveillance | 1 | 2019 | 2596 | 0.310 |
Why?
|
Snake Bites | 2 | 2018 | 29 | 0.290 |
Why?
|
Anemia | 1 | 2017 | 1514 | 0.290 |
Why?
|
Ecosystem | 2 | 2022 | 494 | 0.280 |
Why?
|
Emigrants and Immigrants | 3 | 2016 | 550 | 0.280 |
Why?
|
Papillomaviridae | 3 | 2018 | 1140 | 0.270 |
Why?
|
Early Detection of Cancer | 3 | 2016 | 3239 | 0.270 |
Why?
|
Humans | 58 | 2024 | 768171 | 0.270 |
Why?
|
HIV Seropositivity | 1 | 2011 | 966 | 0.260 |
Why?
|
Adult | 29 | 2024 | 223646 | 0.250 |
Why?
|
Ehrlichia | 1 | 2024 | 6 | 0.240 |
Why?
|
Ticks | 1 | 2024 | 71 | 0.230 |
Why?
|
Vulnerable Populations | 3 | 2019 | 718 | 0.230 |
Why?
|
Protective Devices | 1 | 2024 | 72 | 0.220 |
Why?
|
Brucella suis | 1 | 2023 | 2 | 0.220 |
Why?
|
Asymptomatic Diseases | 2 | 2017 | 590 | 0.220 |
Why?
|
Brucellosis | 1 | 2023 | 21 | 0.220 |
Why?
|
Mass Screening | 2 | 2018 | 5458 | 0.220 |
Why?
|
Swine Diseases | 1 | 2023 | 61 | 0.210 |
Why?
|
Physicians | 2 | 2019 | 4598 | 0.210 |
Why?
|
Universities | 2 | 2019 | 1005 | 0.210 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2024 | 209 | 0.210 |
Why?
|
Histoplasmosis | 1 | 2023 | 63 | 0.210 |
Why?
|
Research | 2 | 2023 | 1979 | 0.210 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2024 | 137 | 0.200 |
Why?
|
Toxoplasmosis | 1 | 2023 | 94 | 0.200 |
Why?
|
Pediatrics | 1 | 2018 | 3629 | 0.200 |
Why?
|
DNA, Viral | 3 | 2018 | 2204 | 0.200 |
Why?
|
Disease Outbreaks | 3 | 2021 | 1761 | 0.180 |
Why?
|
Papillomavirus Infections | 3 | 2018 | 1640 | 0.180 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 404 | 0.180 |
Why?
|
Medicine, Traditional | 1 | 2021 | 89 | 0.180 |
Why?
|
Female | 30 | 2024 | 397187 | 0.180 |
Why?
|
Prevalence | 7 | 2021 | 15869 | 0.180 |
Why?
|
Hepatitis B virus | 2 | 2022 | 533 | 0.160 |
Why?
|
Phytotherapy | 1 | 2021 | 298 | 0.160 |
Why?
|
Treponema pallidum | 1 | 2019 | 48 | 0.160 |
Why?
|
Male | 23 | 2024 | 364731 | 0.160 |
Why?
|
Middle Aged | 18 | 2024 | 223487 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4058 | 0.150 |
Why?
|
Anopheles | 1 | 2020 | 193 | 0.150 |
Why?
|
Young Adult | 13 | 2024 | 60066 | 0.150 |
Why?
|
Mycobacterium ulcerans | 1 | 2017 | 9 | 0.140 |
Why?
|
Arbovirus Infections | 1 | 2017 | 21 | 0.140 |
Why?
|
Internship and Residency | 1 | 2018 | 5953 | 0.140 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2018 | 2185 | 0.140 |
Why?
|
Dengue | 1 | 2020 | 258 | 0.140 |
Why?
|
France | 2 | 2024 | 497 | 0.140 |
Why?
|
Serologic Tests | 1 | 2019 | 382 | 0.140 |
Why?
|
Risk-Taking | 1 | 2022 | 1023 | 0.140 |
Why?
|
Phylogeny | 1 | 2024 | 2843 | 0.130 |
Why?
|
Demography | 1 | 2021 | 1641 | 0.130 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6395 | 0.130 |
Why?
|
Drug Resistance | 2 | 2021 | 1599 | 0.130 |
Why?
|
Internationality | 1 | 2021 | 1008 | 0.120 |
Why?
|
Pilot Projects | 2 | 2019 | 8741 | 0.120 |
Why?
|
International Cooperation | 1 | 2021 | 1436 | 0.120 |
Why?
|
Incidence | 5 | 2023 | 21538 | 0.110 |
Why?
|
Cytodiagnosis | 1 | 2018 | 452 | 0.110 |
Why?
|
Microcephaly | 1 | 2018 | 426 | 0.110 |
Why?
|
Health Services Research | 1 | 2021 | 1815 | 0.110 |
Why?
|
Military Personnel | 1 | 2023 | 1261 | 0.110 |
Why?
|
Adolescent | 9 | 2024 | 89169 | 0.110 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 703 | 0.100 |
Why?
|
Immunoassay | 1 | 2016 | 746 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2022 | 4055 | 0.100 |
Why?
|
Treatment Refusal | 1 | 2016 | 433 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1595 | 0.100 |
Why?
|
Medical Records | 1 | 2018 | 1410 | 0.100 |
Why?
|
Motivation | 1 | 2022 | 2020 | 0.100 |
Why?
|
Africa, Western | 1 | 2011 | 160 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2018 | 26421 | 0.100 |
Why?
|
Qualitative Research | 1 | 2022 | 3140 | 0.090 |
Why?
|
Microscopy | 1 | 2016 | 909 | 0.090 |
Why?
|
Employment | 1 | 2017 | 1110 | 0.090 |
Why?
|
Acculturation | 1 | 2011 | 179 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 6082 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3721 | 0.090 |
Why?
|
Healthcare Disparities | 2 | 2016 | 3415 | 0.090 |
Why?
|
Infant | 5 | 2020 | 36535 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.080 |
Why?
|
Unsafe Sex | 1 | 2011 | 239 | 0.080 |
Why?
|
Caregivers | 1 | 2021 | 2302 | 0.080 |
Why?
|
Interview, Psychological | 1 | 2011 | 810 | 0.080 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2016 | 1099 | 0.080 |
Why?
|
Animals | 8 | 2024 | 169285 | 0.070 |
Why?
|
Child, Preschool | 4 | 2020 | 42669 | 0.070 |
Why?
|
Prejudice | 1 | 2011 | 574 | 0.070 |
Why?
|
Confidentiality | 1 | 2011 | 607 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3620 | 0.070 |
Why?
|
Health Education | 2 | 2024 | 1059 | 0.070 |
Why?
|
Child | 5 | 2024 | 80917 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 2972 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1742 | 0.060 |
Why?
|
Brain Injuries | 1 | 2017 | 2057 | 0.060 |
Why?
|
Causality | 1 | 2011 | 1254 | 0.060 |
Why?
|
Hospitals | 1 | 2019 | 3886 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2539 | 0.060 |
Why?
|
Social Stigma | 1 | 2011 | 788 | 0.060 |
Why?
|
Guyana | 1 | 2024 | 17 | 0.060 |
Why?
|
Europe | 2 | 2022 | 3436 | 0.060 |
Why?
|
Fever | 2 | 2023 | 1614 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59626 | 0.060 |
Why?
|
Primaquine | 1 | 2024 | 28 | 0.060 |
Why?
|
Ehrlichiosis | 1 | 2024 | 28 | 0.060 |
Why?
|
Leishmania | 1 | 2024 | 75 | 0.060 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2024 | 94 | 0.060 |
Why?
|
Aged | 9 | 2024 | 171502 | 0.050 |
Why?
|
Survival Rate | 2 | 2016 | 12840 | 0.050 |
Why?
|
South America | 1 | 2023 | 180 | 0.050 |
Why?
|
Chloroquine | 1 | 2024 | 276 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11244 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Age Factors | 2 | 2016 | 18415 | 0.050 |
Why?
|
Sus scrofa | 1 | 2023 | 430 | 0.050 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2022 | 294 | 0.050 |
Why?
|
Human Activities | 1 | 2021 | 26 | 0.050 |
Why?
|
Plants, Medicinal | 1 | 2021 | 167 | 0.040 |
Why?
|
Metagenomics | 1 | 2024 | 474 | 0.040 |
Why?
|
Health Behavior | 1 | 2011 | 2650 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2024 | 1049 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2023 | 373 | 0.040 |
Why?
|
Genome, Bacterial | 1 | 2024 | 796 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2020 | 2118 | 0.040 |
Why?
|
Snakes | 1 | 2018 | 27 | 0.040 |
Why?
|
Martinique | 1 | 2018 | 1 | 0.040 |
Why?
|
Guadeloupe | 1 | 2018 | 2 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2022 | 467 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5520 | 0.040 |
Why?
|
North America | 1 | 2021 | 1289 | 0.040 |
Why?
|
Pregnancy Trimesters | 1 | 2018 | 197 | 0.030 |
Why?
|
Mutation | 1 | 2021 | 30237 | 0.030 |
Why?
|
Women's Health Services | 1 | 2017 | 87 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6330 | 0.030 |
Why?
|
Sexually Transmitted Diseases, Viral | 1 | 2016 | 39 | 0.030 |
Why?
|
Refusal to Treat | 1 | 2016 | 43 | 0.030 |
Why?
|
Amniotic Fluid | 1 | 2018 | 381 | 0.030 |
Why?
|
Protozoan Proteins | 1 | 2021 | 844 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1344 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1597 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2018 | 498 | 0.030 |
Why?
|
Cytological Techniques | 1 | 2017 | 218 | 0.030 |
Why?
|
Latin America | 1 | 2016 | 416 | 0.030 |
Why?
|
Poverty Areas | 1 | 2016 | 268 | 0.030 |
Why?
|
Learning | 1 | 2024 | 1759 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1524 | 0.030 |
Why?
|
Vaginal Smears | 1 | 2017 | 505 | 0.030 |
Why?
|
Carrier State | 1 | 2017 | 529 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2017 | 677 | 0.030 |
Why?
|
Cervix Uteri | 1 | 2017 | 577 | 0.030 |
Why?
|
Swine | 1 | 2023 | 5997 | 0.030 |
Why?
|
Genotype | 2 | 2018 | 13045 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2722 | 0.030 |
Why?
|
Prospective Studies | 1 | 2017 | 54924 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2018 | 916 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2024 | 81760 | 0.020 |
Why?
|
Pandemics | 2 | 2023 | 8747 | 0.020 |
Why?
|
Papillomavirus Vaccines | 1 | 2018 | 497 | 0.020 |
Why?
|
Pregnancy | 3 | 2018 | 30255 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2016 | 1328 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36741 | 0.020 |
Why?
|
Ultrasonography, Prenatal | 1 | 2017 | 1772 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2016 | 1354 | 0.020 |
Why?
|
Cesarean Section | 1 | 2017 | 1425 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21207 | 0.020 |
Why?
|
Rural Population | 1 | 2018 | 2325 | 0.020 |
Why?
|
Child Development | 1 | 2017 | 2330 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 13013 | 0.020 |
Why?
|
Survival Analysis | 1 | 2016 | 10099 | 0.010 |
Why?
|
Public Health | 1 | 2016 | 2679 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3269 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7852 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15453 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10840 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24318 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39354 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 30009 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41753 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 74944 | 0.000 |
Why?
|
Concepts
(222)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_